MOEBIUS; Hans-Joerg

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOEBIUS; Hans-Joerg.The latest application filed is for "combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors".

Company Profile

0.0.11

MOEBIUS; Hans-Joerg - WOLLERAU CH
MOEBIUS; Hans-Joerg - Zurich CH
Moebius; Hans-Joerg - Frankfurt Am Main DE
Moebius; Hans-Joerg - Frankfurt DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy Using 1-aminocyclohexane Derivatives And Acetylcholinesterase Inhibitors App 20210169864 - MOEBIUS; Hans-Joerg	2021-06-10
Combination Therapy Using 1-aminocyclohexane Derivatives And Acetylcholinesterase Inhibitors App 20160136144 - MOEBIUS; Hans-Joerg	2016-05-19
Combination Therapy Using 1-aminocyclohexane Derivatives And Acetylcholinesterase Inhibitors App 20140371260 - Moebius; Hans-Joerg	2014-12-18
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors App 20100227852 - Moebius; Hans-Joerg	2010-09-09
Memantine For The Treatment Of Childhood Behavioral Disorders App 20100081723 - Jonas; Jeffrey ; et al.	2010-04-01
Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's Disease App 20100048726 - McDonald; Scott ; et al.	2010-02-25
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase and inhibitors App 20090124659 - Moebius; Hans-Joerg	2009-05-14
Memantine for the treatment of childhood behavioral disorders App 20060079582 - Jonas; Jeffrey ; et al.	2006-04-13
Memantine for the treatment of mild and mild to moderate Alzheimer's disease App 20060020042 - McDonald; Scott ; et al.	2006-01-26
1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease App 20050203191 - McDonald, Scott ; et al.	2005-09-15
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors App 20040087658 - Moebius, Hans-Joerg	2004-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.